forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide RA prescription trends: January 2018 – March GLP-1 Market Trends and Global

Doctors use it for the treatment of diabetes, especially for people with type 2 diabetes

Todays pricing move likely reflects a reaction to Novos softening market share as the company looks to regain its footing. Novo and Lilly have even pledged to offer their upcoming oral GLP-1 medications at rock-bottom pricing, drawing a line in the sand before the market even kicks off

Non-arteritic anterior ischemic optic neuropathy, or NAION, is a sudden, painless loss of vision caused by a failure of blood supply to the optic nerve head

Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma

Our expert providers will guide you on how to self-administer the injections of the medication, which you will do once a week

Since May, the Danish Medicines Agency has received 4 more reports of NAION, bringing the total of Danish reports to 32